Brief: Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Business Update
Aug 10 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O :
* CYCLACEL PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* CASH RUNWAY INTO 2H 2023
* QTRLY LOSS PER SHARE $0.46
* Q2 EARNINGS PER SHARE VIEW $-0.63 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7JvBhL
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Green Med Solution
See all newsBrief: Bio Green Med Solution Announces Business Combination Agreement To Acquire Future NRG
Bio Green Med Solution Q1 product revenue hits $0.8 mln, net loss narrows
Brief: Bio Green Med Solution Inc Q1 Net Income USD -197 Thousand
Malaysia's Bio Green Med Solution Q4 net loss narrows
Brief: Bio Green Med Solution Inc Q4 Net Income USD -611 Thousand